GLB - Ticker AI Digest

Glanbia plc 📰 1
TradingFloor AI GO VIP Login

Digested News

Today's Catalysts (GLB) 1
GLB 06:01
Glanbia plc
Transaction in Own Shares
AI 0
No items for this category on selected date.
Acquisitions 0
No items for this category on selected date.
Agreement 0
No items for this category on selected date.
Approvals 0
No items for this category on selected date.
Authorisation 0
No items for this category on selected date.
Awards 0
No items for this category on selected date.
BTC 0
No items for this category on selected date.
Blockchain 0
No items for this category on selected date.
Breakthrough 0
No items for this category on selected date.
BuyBack 0
No items for this category on selected date.
Cancellations 0
No items for this category on selected date.
CashOffer 0
No items for this category on selected date.
Collaborate 0
No items for this category on selected date.
ContractWin 0
No items for this category on selected date.
Covid-19 0
No items for this category on selected date.
Deals 0
No items for this category on selected date.
Diamond 0
No items for this category on selected date.
DirectorDealing 1
GLB 10:59
Glanbia plc
Director/PDMR Shareholding
Discovery 0
No items for this category on selected date.
Exceeded 0
No items for this category on selected date.
FCA 0
No items for this category on selected date.
FDA 0
No items for this category on selected date.
Grants 0
No items for this category on selected date.
InvestmentPlan 0
No items for this category on selected date.
JV 0
No items for this category on selected date.
Launch 1
GLB 06:31
Glanbia plc
Glanbia launches share buyback
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
**Summary**
Glanbia plc, the Better Nutrition company, announced on February 25, 2026, the launch of a share buyback program valued up to €50 million. The program aims to reduce the companys share capital by repurchasing and canceling ordinary shares. It will run from February 25, 2026, to September 30, 2026, unless terminated earlier, and is part of a larger €100 million buyback initiative. J&E Davy (Davy) will act as the principal for share purchases, operating independently within pre-set parameters. The buyback will initially be conducted under the authority granted at the 2025 Annual General Meeting (AGM), allowing repurchase of up to 10% of issued share capital (13,865,688 shares post-previous buybacks). Continuation beyond April 29, 2026, is contingent on shareholder approval at the 2026 AGM. The program complies with Euronext Dublin Listing Rules, EU Market Abuse Regulations, and Central Bank of Ireland guidelines. Glanbia confirmed it holds no unpublished inside information. Contact details for key executives and Davy representatives were provided.
Litigation 0
No items for this category on selected date.
NewContract 0
No items for this category on selected date.
Offers 0
No items for this category on selected date.
Offtake 0
No items for this category on selected date.
Orders 0
No items for this category on selected date.
Partner 0
No items for this category on selected date.
Patents 0
No items for this category on selected date.
Placing 0
No items for this category on selected date.
Positive 0
No items for this category on selected date.
Proposals 0
No items for this category on selected date.
Reports 0
No items for this category on selected date.
Results 1
GLB 06:01
Glanbia plc
Glanbia Full Year 2025 Results
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
**Summary of Glanbia Full Year 2025 Results**
Glanbia plc, the Better Nutrition company, reported robust financial results for the 2025 fiscal year, ending January 3, 2026. Key highlights include
**Revenue Growth**Revenue increased by 2.3% to $3.9 billion, driven by like-for-like (LFL) growth across all three segments: Performance Nutrition (PN), Health & Nutrition (H&N), and Dairy Nutrition (DN).
**EBITDA Decline**EBITDA decreased by 9.4% to $499.1 million, primarily due to record whey input costs affecting the PN segment.
**Adjusted EPS**Adjusted earnings per share (EPS) declined by 3.4% to 134.93 cents, while basic EPS increased by 19.7% to 73.16 cents.
**Segment Performance**
**Performance Nutrition**LFL revenue growth of 4.5%, with Optimum Nutrition achieving 6.4% growth. EBITDA margin declined to 13.0% due to high whey costs.
**Health & Nutrition**LFL revenue growth of 6.8%, with strong volume growth. EBITDA margin improved to 18.4%.
**Dairy Nutrition**LFL volume growth of 4.2%, with EBITDA of $149.5 million.
**Capital Allocation**
Recommended a final dividend of 25.67 €cent, bringing the total 2025 dividend to 42.87 €cent, a 10% increase.
Returned €197 million to shareholders via share buybacks and approved an additional €100 million buyback for 2026.
**Strategic Updates**
Sold non-core brands SlimFast and Body & Fit.
Acquired Sweetmix and Scicore to enhance global scale in H&N.
Continued a group-wide transformation program targeting $60 million in annual cost savings by 2027.
**2026 Outlook**
Expects adjusted EPS growth of 7% to 11% and operating cash conversion of 85%+.
Segmental performance is expected to align with medium-term targets.
CEO Hugh McGuire emphasized the Groups resilience despite macroeconomic challenges, highlighting strong cash flow, strategic acquisitions, and progress on cost-saving initiatives. Glanbia remains focused on its medium-term targets, positioning itself as a leader in better nutrition.
Significant 0
No items for this category on selected date.
Speculation 0
No items for this category on selected date.
Strategic 0
No items for this category on selected date.
Suspension 0
No items for this category on selected date.
TR1 0
No items for this category on selected date.
Takeover 0
No items for this category on selected date.
Understanding 0
No items for this category on selected date.
Updates 0
No items for this category on selected date.
Vaccine 0
No items for this category on selected date.
Wins 0
No items for this category on selected date.
Worth 0
No items for this category on selected date.
All Market News (Last 30 Days) 12
GLB 06:01
Glanbia plc
Transaction in Own Shares
GLB 06:01
Glanbia plc
Transaction in Own Shares
GLB 06:01
Glanbia plc
Transaction in Own Shares
GLB 06:01
Glanbia plc
Transaction in Own Shares
GLB 10:59
Glanbia plc
Director/PDMR Shareholding
GLB 07:45
Glanbia plc
Total Voting Rights
GLB 06:01
Glanbia plc
Transaction in Own Shares
GLB 06:01
Glanbia plc
Transaction in Own Shares
GLB 06:01
Glanbia plc
Dividend Payment Date
GLB 06:01
Glanbia plc
Transaction in Own Shares
GLB 06:31
Glanbia plc
Glanbia launches share buyback
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
**Summary**
Glanbia plc, the Better Nutrition company, announced on February 25, 2026, the launch of a share buyback program valued up to €50 million. The program aims to reduce the companys share capital by repurchasing and canceling ordinary shares. It will run from February 25, 2026, to September 30, 2026, unless terminated earlier, and is part of a larger €100 million buyback initiative. J&E Davy (Davy) will act as the principal for share purchases, operating independently within pre-set parameters. The buyback will initially be conducted under the authority granted at the 2025 Annual General Meeting (AGM), allowing repurchase of up to 10% of issued share capital (13,865,688 shares post-previous buybacks). Continuation beyond April 29, 2026, is contingent on shareholder approval at the 2026 AGM. The program complies with Euronext Dublin Listing Rules, EU Market Abuse Regulations, and Central Bank of Ireland guidelines. Glanbia confirmed it holds no unpublished inside information. Contact details for key executives and Davy representatives were provided.
GLB 06:01
Glanbia plc
Glanbia Full Year 2025 Results
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
**Summary of Glanbia Full Year 2025 Results**
Glanbia plc, the Better Nutrition company, reported robust financial results for the 2025 fiscal year, ending January 3, 2026. Key highlights include
**Revenue Growth**Revenue increased by 2.3% to $3.9 billion, driven by like-for-like (LFL) growth across all three segments: Performance Nutrition (PN), Health & Nutrition (H&N), and Dairy Nutrition (DN).
**EBITDA Decline**EBITDA decreased by 9.4% to $499.1 million, primarily due to record whey input costs affecting the PN segment.
**Adjusted EPS**Adjusted earnings per share (EPS) declined by 3.4% to 134.93 cents, while basic EPS increased by 19.7% to 73.16 cents.
**Segment Performance**
**Performance Nutrition**LFL revenue growth of 4.5%, with Optimum Nutrition achieving 6.4% growth. EBITDA margin declined to 13.0% due to high whey costs.
**Health & Nutrition**LFL revenue growth of 6.8%, with strong volume growth. EBITDA margin improved to 18.4%.
**Dairy Nutrition**LFL volume growth of 4.2%, with EBITDA of $149.5 million.
**Capital Allocation**
Recommended a final dividend of 25.67 €cent, bringing the total 2025 dividend to 42.87 €cent, a 10% increase.
Returned €197 million to shareholders via share buybacks and approved an additional €100 million buyback for 2026.
**Strategic Updates**
Sold non-core brands SlimFast and Body & Fit.
Acquired Sweetmix and Scicore to enhance global scale in H&N.
Continued a group-wide transformation program targeting $60 million in annual cost savings by 2027.
**2026 Outlook**
Expects adjusted EPS growth of 7% to 11% and operating cash conversion of 85%+.
Segmental performance is expected to align with medium-term targets.
CEO Hugh McGuire emphasized the Groups resilience despite macroeconomic challenges, highlighting strong cash flow, strategic acquisitions, and progress on cost-saving initiatives. Glanbia remains focused on its medium-term targets, positioning itself as a leader in better nutrition.

AI Crunch

Single-Ticker AI Crunch
GLB signal theatre built from scored market catalysts, automated AI forecasts, and live trigger logic.

This is the ticker-specific AI Crunch desk for Glanbia plc. It compresses bullish and bearish catalyst scoring, best and worst AI forecast paths, and automated buy or sell trigger logic into one cockpit so users can judge conviction without hopping across screens.

Subscription Required Bullish vs Bearish Scoring AI Forecast Stack Buy / Sell Trigger Engine Catalyst Ledger
Create Account Member Login
Subscriber Unlock
Subscribe to unlock the full GLB AI Crunch cockpit.

Subscription turns this tab into a live signal desk with bullish vs bearish machine scoring, AI forecast stack comparisons, buy and sell trigger logic, and the full catalyst ledger behind every scored catalyst row.

  • AI-scored market headlines with sentiment buckets and buzzword breakdowns.
  • Forecast leaders ranked by projected gain against current market price.
  • Advanced technical scans, AI forecast stacks, and predictive MACD inside the live stock terminal charts.
  • Single-ticker AI Crunch desks with buy or sell trigger logic and full catalyst ledgers.
  • Scored earnings shock board with predicted direction, sector pulse and catalyst narrative.
  • Fast market scan built for event-driven trading, not passive dashboards.
Subscribe to unlock the ticker-specific signal stack, sentiment gauges, forecast stage, and the full catalyst ledger for GLB on 2026-03-06.

Fundamentals Matrix

Overall Fundamentals
Signal: Pending
Capital Strength
Signal: Pending
Float Liquidity
Signal: Pending
Short Pressure
Signal: Pending
Target Setup
Signal: Pending
Market Profile
Signal: Pending
Market Cap
4257163008
Enterprise Value
3877975904
Public Float
81.76
Broker Target
15.9
Shares Out
241691264
Long Interest
100
Short Interest
-
Exchange
LSE
Currency Code
EUR
ISIN
IE0000669501
Market
LSE - MAIN MARKET
Sector
Food Producers
Float / Shares Ratio
-
Short vs Long Delta
-
EV / Market Cap
-

Financials Matrix

Overall Stability
Signal: Pending
Profitability
Signal: Pending
Debt & Cash
Signal: Pending
Valuation Risk
Signal: Pending
Forward Expectation
Signal: Pending
Dividend Safety
Signal: Pending
Divi Rate
0.43
Ex Divi
2026-03-19
Earnings Date
2026-02-25
Net Debt
722586125.0
Cash
491258552.0
EPS
0.62
Net Income
190773127.0
Revenue
4107294469.0
Enterprise Value
3877975904
Trailing PE
0.2789
Forward PE
13.587
Price Sales TTM
1.0787
Price Book MRQ
2.5256
EV Revenue
1.3763
EV EBITDA
14.0271

Capital Radar

Capital Regime
—
Building signal blend...
Smart Money Tilt
—
Public vs institutions
Target Conviction
—
Broker coverage pulse
Insider Pressure
—
Director + TR1 flow
Last Held Position
-
Public Hands
-
Institutions
53.009
Institutions As Of
2025-08-20
Avg Broker Target
-
Upside Vs Price
-
Purchase Director Dealing
1
Sale Director Dealing
7
Purchase TR1
3
Sale TR1
0
Broker Coverage Rows
5
Institution Holders Tracked
2
Public Vs Institutional Ownership (3D)
Top Institution Holders (Latest Per Holder)
Director Dealing Sentiment Flow
Broker Target Bias
Signal: Pending
Capital Momentum Matrix
Broker Targets Vs Price
Aggregated Institution Weight By Holder

Short Data - Last 30 Days

Nexus Pulse Engine

Overall Buy/Sell/Hold
Signal: Pending
Technical Composite
Signal: Pending
Financial Composite
Signal: Pending
Fundamental Composite
Signal: Pending
Short Pressure
Signal: Pending
Momentum Bias
Signal: Pending

Volatility Lab

ATR(14)
Realized Vol (20d)
Volume Spike Z

AI Charts

Today's Catalysts

1 live catalyst just hit GLB.

The headlines landing in Digested News are now framed here as today's catalyst tape. Scroll the tab rail to Digested News or jump there instantly below.
Live Tape Data 2026-03-06 AI Charts Landing View
Scroll the tab rail to Digested News any time, or use the jump button to land straight on today's tape.
1 Today
Catalyst Pulse
Glanbia plc has fresh news flow feeding the chart narrative.
06:01 Today's Catalyst Transaction in Own Shares
AI Charts Studio
GLB Price History
Live structure, automated forecasts, technical overlays and catalyst beacons in one chart workspace.
30 Day View Window 30D Data 2026-03-06 Open Preview Studio Brief
Chart Intelligence Suite
Swipe the timeframe, call the overlays, and keep the AI signal stack fused into one chart cockpit.
The mobile chart console is now framed as one connected surface so forecasting, structure, catalyst beacons and chart tools all sit inside the price workspace.

Automated signalling scans momentum shifts, crossovers and volatility breaks in real time. Automated AI forecasts map best, average and worst simulation paths forward, predictive MACD extends the momentum story, and catalyst beacons pin market-moving headlines directly onto price action so users can connect news, signals and structure without leaving the chart.

Automated Signalling Automated AI Forecasts Predictive MACD Catalyst Beacons Live Price Structure
TradingFloor AI Member Login
Indicators0
Technicals0
AI Forecast 1.02%
RSI Gauge
Price Change
AI Forecast